IC50 values for gliclazide concentration-inhibition relationships of the indicated KATP channels
| Channel | Nucleotide | No nucleotide | +Nucleotide |
| Kir6.2/SUR1 | 100 µM MgADP | 77 ± 11 nM (n = 6) | 245 ± 29 nMa (n = 6) |
| Kir.2/SUR2A-YS | 100 µM MgADP | 1.2 ± 0.2 µM (n = 5) | 2.3 ± 0.6 µM (n = 5) |
| Kir6.2-G334D/SUR1 | 1 mM MgATP | 72 ± 12 nM (n = 6) | 240 ± 42 nMa (n = 6) |
| Kir.2-G334D/SUR2A-YS | 1 mM MgATP | 1.6 ± 0.5 µM (n = 5) | 2.9 ± 1.1 µM (n = 5) |
| Channel | Nucleotide | No nucleotide | +Nucleotide |
| Kir6.2/SUR1 | 100 µM MgADP | 77 ± 11 nM (n = 6) | 245 ± 29 nMa (n = 6) |
| Kir.2/SUR2A-YS | 100 µM MgADP | 1.2 ± 0.2 µM (n = 5) | 2.3 ± 0.6 µM (n = 5) |
| Kir6.2-G334D/SUR1 | 1 mM MgATP | 72 ± 12 nM (n = 6) | 240 ± 42 nMa (n = 6) |
| Kir.2-G334D/SUR2A-YS | 1 mM MgATP | 1.6 ± 0.5 µM (n = 5) | 2.9 ± 1.1 µM (n = 5) |
All values are the mean of the fits to the individual dose–response curves.
P < 0.01 against 0 mM nucleotide (by Student’s t test).